Related Experiment Video
Updated: Jun 14, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Diastolic dysfunction in diabetes and the metabolic syndrome: promising potential for diagnosis and prognosis
H von Bibra1, M St John Sutton
1Clinic for Endocrinology, Diabetes and Vascular Medicine, Klinikum Bogenhausen, Städt. Klinikum München GmbH, Englschalkingerstrasse 77, 81925 Munich, Germany. von-Bibra@extern.lrz-muenchen.de
Insights
Diastolic dysfunction is common in diabetes and metabolic syndrome, impacting heart function. New imaging techniques help quantify this, revealing links to metabolic health and potential therapeutic targets.
Area of Science:
- Cardiology
- Metabolic Diseases
- Medical Imaging
Background:
- Cardiac disease in diabetes mellitus and metabolic syndrome involves vascular and myocardial issues, primarily diastolic dysfunction.
- Evaluating diastolic dysfunction is challenging due to limitations of traditional Doppler echocardiography.
- New imaging technologies offer detailed quantification of diastolic function.
Purpose of the Study:
- To highlight the prevalence and evaluation challenges of diastolic dysfunction in diabetes and metabolic syndrome.
- To discuss the role of advanced imaging techniques like tissue Doppler imaging and cine magnetic resonance imaging (CMR).
- To explore the relationship between cardiovascular risk factors, myocardial bioenergetics, and diastolic dysfunction.
Main Methods:
- Utilizing tissue Doppler imaging for quantifying subclinical diastolic dysfunction in clinical practice.
- Employing cine magnetic resonance imaging (CMR) as a research tool for molecular mechanisms.
- Analyzing the linear decline of diastolic function with age in normal individuals.
Main Results:
- Diastolic dysfunction in diabetes and metabolic syndrome is influenced by cardiovascular risk factors affecting myocardial stiffness and energy metabolism.
- Improvements in diastolic function correlate with better metabolic control through therapy or lifestyle changes.
- Diastolic dysfunction reflects the myocardial structural and metabolic state.
Conclusions:
- Diastolic dysfunction is a key indicator of cardiac issues in diabetes and metabolic syndrome.
- Advanced imaging techniques are crucial for accurate assessment and research.
- Targeting myocardial metabolism offers potential therapeutic strategies to prevent heart failure in insulin resistance and diabetes.
Abstract:
Cardiac disease in diabetes mellitus and in the metabolic syndrome consists of both vascular and myocardial abnormalities. The latter are characterised predominantly by diastolic dysfunction, which has been difficult to evaluate in spite of its prevalence. While traditional Doppler echocardiographic parameters enable only semiquantitative assessment of diastolic function and cannot reliably distinguish perturbations in loading conditions from altered diastolic functions, new technologies enable detailed quantification of global and regional diastolic function. The most readily available technique for the quantification of subclinical diastolic dysfunction is tissue Doppler imaging, which has been integrated into routine contemporary clinical practice, whereas cine magnetic resonance imaging (CMR) remains a promising complementary research tool for investigating the molecular mechanisms of the disease. Diastolic function is reported to vary linearly with age in normal persons, decreasing by 0.16 cm/s each year. Diastolic function in diabetes and the metabolic syndrome is determined by cardiovascular risk factors that alter myocardial stiffness and myocardial energy availability/bioenergetics. The latter is corroborated by the improvement in diastolic function with improvement in metabolic control of diabetes by specific medical therapy or lifestyle modification. Accordingly, diastolic dysfunction reflects the structural and metabolic milieu in the myocardium, and may allow targeted therapeutic interventions to modulate cardiac metabolism to prevent heart failure in insulin resistance and diabetes.
Related Concept Videos
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetes: Symptoms, Diagnosis, and Complications
Type II Diabetes II: Pathophysiology
Coronary Artery Disease I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
Type I Diabetes II: Pathophysiology
